Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPY5R | Q15761 | 14/20 | 0.44 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.40 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.40 |
| ▸ | P2RY12 | Q9H244 | 1/20 | 0.40 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.39 |
| ▸ | NPC1 | O15118 | 1/20 | 0.38 |
| ▸ | TP53 | P04637 | 1/20 | 0.38 |
| ▸ | RAB9A | P51151 | 1/20 | 0.38 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.38 |
| ▸ | LIMK1 | P53667 | 1/20 | 0.37 |
| ▸ | LIMK2 | P53671 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13273848 | 1.00 | NPY5R (0.44) | NPY5RHSD17B10NPSR1P2RY12KDM4E | |
| SCHEMBL2802647 | 0.90 | NPY5R (0.43) | NPY5RKDM4E | |
| SCHEMBL2802649 | 0.90 | NPY5R (0.43) | NPY5RKDM4E | |
| SCHEMBL2802712 | 0.89 | HDAC3 (0.47) | NPY5RKDM4ENPC1RAB9ASMN1; SMN2 | |
| SCHEMBL2802715 | 0.89 | HDAC3 (0.47) | NPY5RKDM4ENPC1RAB9ASMN1; SMN2 | |
| SCHEMBL2803858 | 0.89 | SMN1; SMN2 (0.50) | NPY5RHSD17B10KDM4ENPC1TP53 | |
| SCHEMBL2803860 | 0.89 | SMN1; SMN2 (0.50) | NPY5RHSD17B10KDM4ENPC1TP53 | |
| SCHEMBL13273931 | 0.89 | NPY5R (0.49) | NPY5RKDM4ESMN1; SMN2 | |
| SCHEMBL2805381 | 0.89 | ALDH1A1 (0.46) | NPY5RNPSR1P2RY12RAB9ASMN1; SMN2 | |
| SCHEMBL2805386 | 0.89 | ALDH1A1 (0.46) | NPY5RNPSR1P2RY12RAB9ASMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8357694-B2 | Substituted 5,6-dihydro-6-phenylbenzo[F]isoquinolin-2-amine compounds | ARQULE, INC. (US) | 2013-01-22 | — | — | US | disclosed |
| US-20100239525-A1 | SUBSTITUTED 5,6-DIHYDRO-6-PHENYLBENZO[F]ISOQUINOLIN-2-AMINE COMPOUNDS | ARQULE, INC. (US) | 2010-09-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100239525-A1 | SUBSTITUTED 5,6-DIHYDRO-6-PHENYLBENZO[F]ISOQUINOLIN-2-AMINE COMPOUNDS | NQO1, DPYD, H4C1; H4C2; H4C3; H4C4; H4C5; H4C6; H4C8; H4C9; H4C11; H4C12; H4C13; H4C14; H4C15; H4C16 | NPY5R 617/4885HSD17B10 2234/4885NPSR1 3420/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.